OBJECTIVES: to describe the course of Italian organized cancer screening programmes during the COVID-19 emergency;to provide estimates of the diagnosis of malignant or pre-malignant lesions that will face a diagnostic delay due to the slowing down of screening activities DESIGN: quantitative survey of aggregated data for each Region and overall for Italy relating to screening tests carried out in the period January-May 2020 compared to those of the same period of 2019;estimate of diagnostic delays starting from the calculation of the average detection rate of the last 3 years available (specific by Region) SETTING AND PARTICIPANTS: Italian mass screening programmes Data on the tests carried out in the target population of the breast (women 50-69 years old), cervix (women 25-64 years old), and colorectal (women and men 50-69 years old) cancer screening MAIN OUTCOME MEASURES: the cumulative delay (in absolute numbers and as a percentage) in the period January-May 2020 compared to the same period of 2019, by Region;the difference of screening tests (in absolute number and in percentage) performed in May 2020 compared to May 2019;the estimate of the fewer lesions diagnosed in 2020 compared with 2019 with relative 95% confidence intervals (95%CI);the 'standard months' of delay (proportion of fewer tests carried out from January to May 2020 for the corresponding number of months) RESULTS: 20 Regions out of 21 participated In the period January-May 2020, the fewer screening tests performed in comparison with the same period of 2019 were: 472,389 (equal to 53 8%) with an average delay of standard months of 2 7 for mammography screening;585,287 (equal to 54 9%) with an average delay of standard months of 2 7 for colorectal screening;371,273 (equal to 55 3%) with an average delay of 2 8 standard months for cervical screening The estimated number of undiagnosed lesions is 2,201 (95%CI 2,173-2,220) breast cancers;645 (95%CI 632-661) colorectal carcinomas;3,890 (95%CI 3,855-3,924) advanced colorectal adenomas and 1,497 (95%CI 1,413-1,586) CIN2 or more serious lesions CONCLUSIONS: mass screenings need to be restarted as quickly as possible In order to make up for the delay that is accumulating, it is necessary to provide for wider delivery times, greater resources, and new organizational approaches It will also be essential to develop communication strategies suitable for promoting participation during this emergency
[Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates]